Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
April 2024
The medical devices information portal connecting healthcare professionals to global vendors
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy
World’s first MRI-guided proton therapy prototype goes into scientific application
, /in Featured Articles /by panglobalIn a world-first, a full-body MRI scanner for real-time imaging has been combined with a proton therapy system to provide a scientific prototype for MRI-guided proton therapy. With this installation in Dresden, Germany, experts from the fields of medicine, medical physics, biology and engineering are embarking on the scientific testing of a new form of […]
Novel MRI technique improves the lasting effects of treatment for severe depression
, /in Featured Articles /by panglobalA major clinical trial has shown that by using MRI and tracking to guide the delivery of magnetic stimulation to the brains of people with severe depression, patients will see their symptoms ease for at least six months, which could vastly improve their quality of life.
Researchers use AI to develop early diagnostic test for ovarian cancer
, /in Featured Articles /by panglobalScientists at the Georgia Tech Integrated Cancer Research Center (ICRC) have combined machine learning with information on blood metabolites to develop a new test able to detect ovarian cancer with 93 percent accuracy among samples from the team’s study group.
WHO releases AI ethics and governance guidance for large multi-modal models
, /in Featured Articles /by panglobalThe World Health Organization (WHO) is releasing new guidance on the ethics and governance of large multi-modal models (LMMs) – a type of fast growing generative artificial intelligence (AI) technology with applications across health care.
Using AI, researchers identify a new class of antibiotic candidates
, /in Featured Articles /by panglobalUsing a type of deep learning artificial intelligence, researchers at the Wyss Institute and MIT have discovered a class of compounds that can kill methicillin-resistant Staphylococcus aureus (MRSA), a drug-resistant bacterium that causes many deaths around the world every year.
Healthcare 21 Group (HC21) showcases cutting-edge support helping international MedTech manufacturers navigate UK market at Arab Health 2024
, /in E-News /by panglobalHealthcare 21 Group (HC21) will be at Arab Health 2024 to showcase their specialist support services designed to help international MedTech manufacturers navigate the UK market with confidence.
Singapore robotics innovator OTSAW to showcase Camello+ multipurpose robot at Arab Health
, /in E-News /by panglobalMarking a pivotal point in a nine-year journey of innovation, OTSAW, a leader in Singapore’s robotics landscape, introduces Camello+, an autonomous mobile robot (AMR) poised to revolutionize various industries, including healthcare.
Arab Health sells out as international exhibitors hit record levels
, /in E-News /by panglobalArab Health will this year welcome over 40 country pavilions, including Serbia and Hong Kong, who will make their debut at the 2024 edition of the event A total of 73 countries will be represented by exhibitors as Arab Health takes over the Dubai World Trade Centre, with a total of 25 halls occupied More […]
SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking
, /in E-News /by panglobalSyntheticMR announced that their next-generation imaging solution with isotropic 3D resolution, SyMRI 3D, has obtained approval in the EU and is now CE-Marked. With preparations in place, SyntheticMR eagerly anticipates the commercial launch of SyMRI 3D at the start of 2024.
SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel
, /in E-News /by panglobalPhase IIa clinical trial evaluated Aurase Wound Gel in patients with venous leg ulcers Former Smith+Nephew CMO, Andy Weymann joins as Chairman to support progression of further Phase II clinical trials